Capital Investment Advisory Services LLC Buys Shares of 2,900 Henry Schein, Inc. (NASDAQ:HSIC)

Capital Investment Advisory Services LLC bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,900 shares of the company’s stock, valued at approximately $220,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Xponance Inc. grew its stake in Henry Schein by 2.1% during the 3rd quarter. Xponance Inc. now owns 21,839 shares of the company’s stock valued at $1,622,000 after acquiring an additional 443 shares in the last quarter. Everett Harris & Co. CA grew its stake in Henry Schein by 29.1% during the 4th quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock valued at $7,925,000 after acquiring an additional 23,622 shares in the last quarter. Sprucegrove Investment Management Ltd. grew its stake in Henry Schein by 14.2% during the 4th quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock valued at $16,693,000 after acquiring an additional 27,500 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Henry Schein by 215.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 74,251 shares of the company’s stock valued at $5,622,000 after buying an additional 50,723 shares in the last quarter. Finally, Caxton Associates LP grew its stake in shares of Henry Schein by 80.8% in the 3rd quarter. Caxton Associates LP now owns 18,991 shares of the company’s stock valued at $1,410,000 after buying an additional 8,486 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 0.6 %

HSIC opened at $73.21 on Thursday. The business has a 50 day moving average price of $74.29 and a 200 day moving average price of $72.43. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $85.39. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. The firm has a market cap of $9.41 billion, a P/E ratio of 23.24, a price-to-earnings-growth ratio of 1.80 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion during the quarter, compared to analyst estimates of $3 billion. During the same quarter last year, the firm posted $1.21 earnings per share. The firm’s revenue for the quarter was down 10.5% compared to the same quarter last year. Research analysts forecast that Henry Schein, Inc. will post 5.07 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on HSIC. Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. SVB Leerink began coverage on Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target for the company. Piper Sandler boosted their price target on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research note on Monday, February 26th. JPMorgan Chase & Co. boosted their price target on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research note on Wednesday, March 6th. Finally, TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $81.09.

Insider Transactions at Henry Schein

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.